Mid-Day Breakouts Report - Wednesday, August 16th, 2023

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - WEDNESDAY, AUGUST 16TH, 2023
Previous Mid Day Report Next Mid Day Report >>>

DOW 34970.15 23.76 (0.07%) | NASDAQ 13571.52 -59.53 (-0.44%) | S&P 500 4436.09 -1.77 (-0.04%)

Time of Screening : 8/16/2023 12:12:06 PM Report Released : 8/16/2023 12:36:51 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AKAM - NASDAQ - INTERNET - Internet Software & Services Akamai Technologies Inc	$102.20	-0.92 -0.89%	$102.92	$107.47	-4.91%	3,361,859 235.10%	1,430,000
Most Recent Note for AKAM - 8/16/2023 12:14:14 PM Gapped up on 8/09/23 hitting a new 52-week high, but it faces resistance due to overhead supply up to the $123 level. Found support near its 50 DMA line during the recent consolidation. Reported earnings +10% on +4% sales revenues for the Jun '23 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Sub par sales revenues growth remains a concern. It was dropped from the Featured Stocks list on 6/15/15.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BBVA - NYSE - BANKING - Foreign Regional Banks Banco Bilbao Viz Arg Adr	$7.75	+0.01 0.06%	$7.76	$8.14	-4.85%	1,463,271 145.02%	1,009,000
Most Recent Note for BBVA - 8/16/2023 12:14:53 PM Consolidating above its 50 DMA line ($7.61) and perched within close striking distance of its 52-week high. Reported strong Mar and Jun '23 quarterly results versus the year-ago periods, but fundamental concerns remain for this Spanish banking firm.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BCSF - NYSE - Financial Svcs-Specialty Bain Capital Specialty Finance	$15.35	+0.25 1.66%	$15.42	$15.85	-3.15%	111,256 60.47%	184,000
Most Recent Note for BCSF - 8/16/2023 12:15:19 PM Hovering near its 52-week high today following a noted spurt of gains marked by volume. Little resistance remains due to old overhead supply. Three of the past 4 quarterly comparisons through Jun '23 showed earnings increases versus the year ago periods above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is a concern. Completed its $20.25 IPO on 11/15/18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CMT - AMEX - CONSUMER NON-DURABLES - Rubber & Plastics Core Mlding Technologies	$26.08	-1.71 -6.14%	$28.34	$27.95	-6.71%	63,492 78.39%	81,000
Most Recent Note for CMT - 8/16/2023 12:18:21 PM There was a "negative reversal" today after hitting a new 52-week high following 6 consecutive volume-driven gains. Very extended from any sound base. Reported earnings +250% on -1% sales revenues for the Jun '23 quarter versus the year-ago period. Fundamental concerns remain. Its up and down annual earnings (A criteria) history is not a match with the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
EXTR - NASDAQ - INTERNET - Internet Software & Services Extreme Networks Inc	$30.00	-2.02 -6.29%	$31.74	$32.73	-8.36%	1,847,168 86.72%	2,130,000
Most Recent Note for EXTR - 8/16/2023 12:21:29 PM Retreating from its 52-week high with heavier volume behind today's 3rd consecutive loss. Very extended from any sound base. Reported Jun '23 quarterly earnings +120% versus the year-ago period. Rallied impressively since noted in the 5/31/23 mid-day report - "Found support near its 200 DMA line during its consolidation in recent months. Quarterly comparisons in Dec '22 and Mar '23 showed improved sales revenues and earnings increases with encouraging acceleration. Prior quarterly and annual earnings (A criteria) history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FMX - NYSE - FOOD & BEVERAGE - Beverages - Brewers Fomento Econ Mex Sab Ads	$116.75	+4.38 3.90%	$116.88	$114.48	1.98%	381,438 78.65%	485,000
Most Recent Note for FMX - 8/16/2023 12:25:45 PM Hitting a new 52-week high with today's big volume-driven gain. Found support at its 50 DMA line during its ongoing ascent. Reported earnings +128% on +39% sales revenues for the Jun '23 quarter, its 2nd strong quarterly comparison. Prior quarterly and annual earnings history (C and A criteria) has not been strong and steady.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HRTG - NYSE - Insurance-Prop/Cas/Titl Heritage Insurance Holdings, Inc	$5.84	+0.00 0.01%	$6.01	$6.09	-4.09%	89,449 64.82%	138,000
Most Recent Note for HRTG - 8/16/2023 12:26:57 PM Perched at its 52-week high following a spurt of volume-driven gains. Reported strong earnings increases for the Mar and Jun '23 versus the year-ago periods. Prior quarterly sales revenues growth was lackluster and earnings increases were below the +25% minimum guideline (C criteria). Its poor annual earnings (A criteria) history is a concern with respect to the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MITK - NASDAQ - Comp Sftwr-Spec Enterprs Mitek System Inc	$11.63	-0.71 -5.75%	$12.41	$12.66	-8.14%	332,363 106.87%	311,000
Most Recent Note for MITK - 8/16/2023 12:29:35 PM Abruptly reversing the prior gain with today's big loss after hitting a new 52-week high. The 8/15/23 mid-day report noted - "Fundamental concerns remain. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been good following a small downturn in FY '18."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MTSI - NASDAQ - Elec-Semiconductor Mfg M/A-COM Technology Sltn	$74.36	-2.14 -2.80%	$76.09	$77.47	-4.01%	284,708 62.44%	456,000
Most Recent Note for MTSI - 8/16/2023 12:31:10 PM Reported earnings -26% on -14% sales revenues for the Jun '23 quarter versus the year ago period. Prior quarterly comparisons have not been strong and steady above the +25% minimum earnings guideline (C criteria) It was dropped from the Featured Stocks list on 8/03/17.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NATI - NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services National Instrument Corp	$58.88	-0.32 -0.54%	$59.01	$59.40	-0.88%	1,478,476 114.52%	1,291,000
Most Recent Note for NATI - 8/16/2023 12:33:12 PM Following M&A news and big volume-driven gains it is consolidating in a tight range near its all-time high. Reported strong Mar and Jun '23 quarterly results. Prior quarterly comparisons versus the year earlier have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) had a downturn in FY '20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NVO - NYSE - DRUGS - Drug Manufacturers - Other Novo Nordisk A/S Adr	$185.46	+0.35 0.19%	$187.05	$192.18	-3.50%	895,476 58.84%	1,522,000
Most Recent Note for NVO - 8/16/2023 12:33:23 PM This Denmark-based Medical - Ethical Drugs firm is consolidating after a considerable gap up on 8/08/23 hitting a new all-time high. Reported Jun '23 quarterly earnings +53% on +37% sales revenues versus the year-ago period, its 2nd strong quarter. Fundamental concerns remain. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
RDY - NYSE - DRUGS - Drug Manufacturers - Other Dr Reddys Labs Ltd Adr	$71.44	+0.37 0.52%	$71.70	$72.13	-0.96%	156,587 66.63%	235,000
Most Recent Note for RDY - 8/16/2023 12:34:24 PM This India-based firm in the Medical - Generic Drugs industry group is hovering near its 52-week high following noted volume-driven gains. Reported Jun '23 quarterly earnings +13% on +24% sales revenues versus the year-ago period. Prior quarterly and annual earnings history (C and A criteria) leaves fundamental concerns.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.